Cyclosporin A combined with vincristine, doxorubicin and dexamethasone (VAD) compared with VAD alone in patients with advanced refractory multiple myeloma: an EORTC–HOVON randomized phase III study (06914)
- 20 December 2001
- journal article
- clinical trial
- Published by Wiley in British Journal of Haematology
- Vol. 115 (4) , 895-902
- https://doi.org/10.1046/j.1365-2141.2001.03171.x
Abstract
The British Journal of Haematology publishes original research papers in clinical, laboratory and experimental haematology. The Journal also features annotations, reviews, short reports, images in haematology and Letters to the Editor.Keywords
This publication has 20 references indexed in Scilit:
- Cellular resistance mechanisms with impact on the therapy of multiple myelomaLeukemia, 1998
- A Prospective, Randomized Trial of Autologous Bone Marrow Transplantation and Chemotherapy in Multiple MyelomaNew England Journal of Medicine, 1996
- Verapamil suppresses the emergence of P-glycoprotein-mediated multi-drug resistanceInternational Journal of Cancer, 1996
- A phase III randomized study of oral verapamil as a chemosensitizer to reverse drug resistance in patients with refractory myeloma. A southwest oncology group studyCancer, 1995
- Clinical significance of P-glycoprotein in multidrug resistance malignancies [editorial] [see comments]Blood, 1993
- P-glycoprotein expression in plasma-cell myeloma is associated with resistance to VADBlood, 1989
- Drug-resistance in multiple myeloma and non-Hodgkin's lymphoma: detection of P-glycoprotein and potential circumvention by addition of verapamil to chemotherapy.Journal of Clinical Oncology, 1989
- Reversal of drug‐resistance in multiple myeloma with verapamilBritish Journal of Haematology, 1988
- Expression of a multidrug-resistance gene in human tumors and tissues.Proceedings of the National Academy of Sciences, 1987
- Combination chemotherapy for multiple myelomaCancer, 1972